Vitamin D Levels in Stage IV Colorectal Cancer Patients: A Phase II Study
Interventional
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Vitamin D level
To determine the ability of achieving the target serum 25-hydroxy vitamin D level of 40 ng/ml within 6 weeks of beginning vitamin D supplements in patients with metastatic colon cancer.
w/i 6 weeks of beginning vitamin D
No
Kathleen Wesa, MD
Principal Investigator
Memorial Sloan-Kettering Cancer Center
United States: Food and Drug Administration
09-143
NCT01074216
February 2010
February 2013
Name | Location |
---|---|
Memorial Sloan Kettering Cancer Center | New York, New York 10021 |
Memoral Sloan Kettering Cancer Center | Basking Ridge, New Jersey |
Memorial Sloan-Kettering Cancer Center @ Suffolk | Commack, New York 11725 |
Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital | Sleepy Hollow, New York |
Memorial Sloan-Kettering at Mercy Medical Center | Rockville Centre, New York |